Takeda swallows bitter pill in cautious dollar market
Takeda Pharmaceutical, the Japanese firm buying UK rival Shire, defied tough market conditions to press ahead with a $5.5bn trade to help fund its $62.5bn acquisition ahead of the Thanksgiving holiday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: